ADVANCE ONLINE PUBLICATION

The latest research papers, published online ahead of print. These online versions are definitive and may be cited using the digital object identifier (DOI).
About advance online publication

Sort articles by article type
Top

November 3 2009

Review

The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy

S P R Romaine, K M Bailey, A S Hall and A J Balmforth

Pharmacogenomics J advance online publication, November 3, 2009; doi:10.1038/tpj.2009.54

Original Articles

Upregulating CD59: a new strategy for protection of neurons from complement-mediated degeneration

M V Kolev, T Tediose, B Sivasankar, C L Harris, J Thome, B P Morgan and R M Donev

Pharmacogenomics J advance online publication, November 3, 2009; doi:10.1038/tpj.2009.52

The modulating effect of the androgen receptor on craving in alcohol withdrawal of men is partially mediated by leptin

B Lenz, H Frieling, C Jacob, A Heberlein, J Kornhuber, S Bleich and T Hillemacher

Pharmacogenomics J advance online publication, November 3, 2009; doi:10.1038/tpj.2009.56

The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patients

P W Schenk, M van Vliet, R A A Mathot, T van Gelder, A G Vulto, M A C van Fessem, S Verploegh-Van Rij, J Lindemans, J A Bruijn and R H N van Schaik

Pharmacogenomics J advance online publication, November 3, 2009; doi:10.1038/tpj.2009.50

Top

October 27 2009

Clinical Implications

Association of SUMO1 and UBC9 genotypes with tumor response in non-small-cell lung cancer treated with irinotecan-based chemotherapy

Ji-Youn Han, Geon Kook Lee, Sun Young Yoo, Sung Jin Yoon, Eun Young Cho, Heung Tae Kim and Jin Soo Lee

Pharmacogenomics J advance online publication, October 27, 2009; doi:10.1038/tpj.2009.46

Top

October 20 2009

News and Commentary

The 8th Annual Pharmacogenetics in Psychiatry Meeting Report

K Aitchison, A Serretti, D Goldman, S Curran, A Drago and A K Malhotra

Pharmacogenomics J advance online publication, October 20, 2009; doi:10.1038/tpj.2009.47

Top

September 29 2009

Original Article

Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients

A V Khrunin, A Moisseev, V Gorbunova and S Limborska

Pharmacogenomics J advance online publication, September 29, 2009; doi:10.1038/tpj.2009.45

Top

September 22 2009

Original Article

An inosine 5'-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid

W Winnicki, G Weigel, G Sunder-Plassmann, T Bajari, B Winter, H Herkner and G Sengoelge

Pharmacogenomics J advance online publication, September 22, 2009; doi:10.1038/tpj.2009.43

Top

September 15 2009

Original Articles

MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome

M Cizmarikova, M Wagnerova, L Schonova, V Habalova, A Kohut, A Linkova, M Sarissky, J Mojzis, L Mirossay and A Mirossay

Pharmacogenomics J advance online publication, September 15, 2009; doi:10.1038/tpj.2009.41

Transcriptome analysis of nicotine-exposed cells from the brainstem of neonate spontaneously hypertensive and Wistar Kyoto rats

M F R Ferrari, E M Reis, J P P Matsumoto and D R Fior-Chadi

Pharmacogenomics J advance online publication, September 15, 2009; doi:10.1038/tpj.2009.42

Association of calpain-10 gene polymorphism and posttransplant diabetes mellitus in kidney transplant patients medicated with tacrolimus

Mateusz Kurzawski, Krzysztof Dziewanowski, Karolina Kedzierska, Wanda Gornik, Anna Banas and Marek Drozdzik

Pharmacogenomics J advance online publication, September 15, 2009; doi:10.1038/tpj.2009.44

Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure

C-K Wu, J-L Luo, C-T Tsai, Y-T Huang, C-L Cheng, J-K Lee, L-Y Lin, J-W Lin, J-J Hwang and F-T Chiang

Pharmacogenomics J advance online publication, September 15, 2009; doi:10.1038/tpj.2009.39

Top

September 1 2009

Original Articles

Association of polymorphisms in the carbonic anhydrase 6 gene with salivary buffer capacity, dental plaque pH, and caries index in children aged 7–9 years

R C R Peres, G Camargo, L S Mofatto, K L Cortellazzi, M C L G Santos, M N Santos, C C Bergamaschi and S R P Line

Pharmacogenomics J advance online publication, September 1, 2009; doi:10.1038/tpj.2009.37

Isolation and characterization of stem cells derived from human third molar tooth germs of young adults: implications in neo-vascularization, osteo-, adipo- and neurogenesis

M E Yalvac, M Ramazanoglu, A A Rizvanov, F Sahin, O F Bayrak, U Salli, A Palotás and G T Kose

Pharmacogenomics J advance online publication, September 1, 2009; doi:10.1038/tpj.2009.40

Top

August 25 2009

Original Article

eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension

V C Sandrim, A C T Palei, M R Luizon, T C Izidoro-Toledo, R C Cavalli and J E Tanus-Santos

Pharmacogenomics J advance online publication, August 25, 2009; doi:10.1038/tpj.2009.38

Top

August 4 2009

Original Article

Application of principal component analysis to pharmacogenomic studies in Canada

H Visscher, C J D Ross, M-P Dubé, A M K Brown, M S Phillips, B C Carleton and M R Hayden

Pharmacogenomics J advance online publication, August 4, 2009; doi:10.1038/tpj.2009.36

Top

July 28 2009

News and Commentary

Matrix metalloproteinase polymorphisms and HIV anti-retroviral drugs: new implications of pharmacogenomics in therapeutic approaches

F Mannello

Pharmacogenomics J advance online publication, July 28, 2009; doi:10.1038/tpj.2009.35

Original Articles

Association of a functional polymorphism in the adrenomedullin gene (ADM) with response to paroxetine

D M Glubb, P C McHugh, X Deng, P R Joyce and M A Kennedy

Pharmacogenomics J advance online publication, July 28, 2009; doi:10.1038/tpj.2009.33

Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome

B Laika, S Leucht, S Heres, H Schneider and W Steimer

Pharmacogenomics J advance online publication, July 28, 2009; doi:10.1038/tpj.2009.32

Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese

Q Zhou, X M Yu, H B Lin, L Wang, Q Z Yun, S N Hu and D-M Wang

Pharmacogenomics J advance online publication, July 28, 2009; doi:10.1038/tpj.2009.31

Top

June 23 2009

Original Article

Influence of ethnicity on pharmacogenetic variation in the Ghanaian population

J L Yen-Revollo, D J Van Booven, E J Peters, J M Hoskins, R M Engen, H D Kannall, D Ofori-Adjei, H L McLeod and S Marsh

Pharmacogenomics J advance online publication, June 23, 2009; doi:10.1038/tpj.2009.28

Top

June 9 2009

Original Article

A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms

P Gassó, S Mas, M Bernardo, S Álvarez, E Parellada and A Lafuente

Pharmacogenomics J advance online publication, June 9, 2009; doi:10.1038/tpj.2009.26

Top

June 2 2009

Original Article

Corticosteroid effects on blood gene expression in Duchenne muscular dystrophy

L Lit, F R Sharp, M Apperson, D Z Liu, W L Walker, I Liao, H Xu, B P Ander and B Wong

Pharmacogenomics J advance online publication, June 2, 2009; doi:10.1038/tpj.2009.22

Top

May 19 2009

Original Article

Intermediate metabolizer: increased side effects in psychoactive drug therapy. The key to cost-effectiveness of pretreatment CYP2D6 screening?

B Laika, S Leucht, S Heres and W Steimer

Pharmacogenomics J advance online publication, May 19, 2009; doi:10.1038/tpj.2009.23

Extra navigation

.

naturejobs

ADVERTISEMENT